Starsource Multitrade

Starsource Multitrade Operating Expenses

The Total Operating Expenses of Starsource Multitrade (506365.BO) as of Oct 21, 2026 is 102,370.00 INR. In the previous year, Total Operating Expenses was 216,000.00 INR — a change of -52.61% (lower).

Operating Expenses

102,370.00INR

YoY

-52.61%

Last updated:

Total Operating Expenses of Starsource Multitrade is 2026 102,370.00 INR. Total Operating Expenses of Starsource Multitrade was 2025 216,000.00 INR. It decreases by -52.61% lower compared to the previous year.

The Starsource Multitrade Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2019
912,617.00 INR
Jan 1, 2020
958,476.00 INR
Jan 1, 2021
329,254.00 INR
Jan 1, 2022
1.28 M INR
Jan 1, 2023
791,330.00 INR
Jan 1, 2024
184,650.00 INR
Jan 1, 2025
216,000.00 INR
Jan 1, 2026
102,370.00 INR
The Starsource Multitrade Operating Expenses history
YEAROperating ExpensesYoY
102,370.00INR-52.61%
216,000.00INR+16.98%
184,650.00INR-76.67%
791,330.00INR-38.32%
1.28 MINR+289.63%
329,254.00INR-65.65%
958,476.00INR+5.02%
912,617.00INR-14.15%
1.06 MINR+41.02%
753,855.00INR+22.78%
613,970.00INR-36.22%
962,672.00INR-19.70%
1.20 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

Total Operating Expenses of Starsource Multitrade is 102,370.00 INR in 2026.

Total Operating Expenses of Starsource Multitrade changed from 216,000.00 INR to 102,370.00 INR, representing a -52.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Starsource Multitrade historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Starsource Multitrade

All Key Metrics — Starsource Multitrade